SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 72.05 |
| Enterprise Value ($M) | 43.38 |
| Book Value ($M) | 52.48 |
| Book Value / Share | 1.12 |
| Price / Book | 1.37 |
| NCAV ($M) | 43.45 |
| NCAV / Share | 0.93 |
| Price / NCAV | 1.66 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.19 |
| Return on Assets (ROA) | -0.57 |
| Return on Equity (ROE) | -0.70 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.28 |
| Current Ratio | 3.59 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 61.29 |
| Assets | 70.32 |
| Liabilities | 17.84 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 25.98 |
| Operating Income | -64.82 |
| Net Income | -63.69 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -59.55 |
| Cash from Investing | 25.20 |
| Cash from Financing | 0.13 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Suvretta Capital Management, Llc | 9.99 | ||
| 13G | ABG Management Ltd. | 6.30 | ||
| 13D/A | Desai Neil | 4.90 | 0.41 | |
| 13D/A | BML Investment Partners, L.P. | 4.98 | 0.00 | |
| 13D/A | Avoro Capital Advisors LLC | 19.99 | 232.64 | |
| 13G/A | Satter Muneer A | 0.00 | -99.96 | |
| 13G | QVT Financial LP | 9.37 | ||
| 13G/A | EcoR1 Capital, LLC | 1.40 | -81.29 | |
| 13G | Point72 Asset Management, L.P. | 6.00 | -19.44 | |
| 13D/A | Acuta Capital Partners, Llc | 7.80 | 24.11 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 15,143 | 49,756 | 30.43 | |
| 34,516 | 131,093 | 26.33 | |
| 7,490 | 29,998 | 24.97 | |
| 4,156 | 24,946 | 16.66 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| VTVT – vTv Therapeutics Inc. | VXRT – Vaxart, Inc. |
| VYNE – VYNE Therapeutics Inc. | WINT – Windtree Therapeutics, Inc. |
| XBIO – Xenetic Biosciences, Inc. |
Financial data and stock pages provided by
Fintel.io